ARCHIVES

Risk-Benefit Analysis Advised Prior To Hormone Therapy

This article is from The Cancer Letter archive.

Vol. 33 No. 8 | August 27, 2010

Download PDF Visit The Full Archive

Related Articles

In Brief: Basic Science Center Funding Plan Clarified; Janice Feldman Leaves As Chief Of NIH Nursing

February 17, 1989

FDA says new tools needed to speed therapeutics development.

March 26, 2004

NCAB Congress to Keep Cigarette Tax At 16 Cents

May 24, 1985

FDA Approves Cyramza for Stomach Cancer; Zykadia in NSCLC; Lipiodol for HCC Imaging; And Cobas HPV Test for Primary Screening

April 25, 2014

New Cancer Control Approaches May Include CCRU RFA, Center Cooperative Groups, Regional “Rounds”

March 18, 1983

Increased Breast Density Can Lead to Higher Risk

August 26, 2011